imu 40c as imugene moves closer commercial sales High potential return.
Our optimistic case valuation remains 40 cents per share, a figure
still some way above the current share price. However we expect
that as Imugene moves closer commercial sales, a significant share
price rise is likely to reflect the increased commercial certainty of
the company.
imu 40c as imugene moves closer commercial sales High potential...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 1177 | 1 |
View Market Depth
| Last trade - 16.21pm 14/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |
Day chart unavailable